Antimicrobial Resistance & CFU Testing
Independent microbiological testing evaluating antimicrobial resistance of Derma Compress over a 20-day simulated use cycle.
Testing Overview
Testing Laboratory:
Pharmichem Testing Services, Inc.
17501 W. Duvan Drive
Tinley Park, Illinois 60477
Protocol Number:
M-018-03
Study Title:
Determination of Antimicrobial Resistance of Derma Compress Against Staphylococcus aureus and Pseudomonas aeruginosa Over a 20 Day Exposure Period CFU Testing #3.
Testing Date:
June / July 2018 CFU Testing #3.
Product Tested:
Derma Compress – 2x10 Vented
Purpose of the Study
This study was conducted to evaluate whether repeated exposure to common wound pathogens would result in cumulative bacterial retention or reduced sanitization effectiveness over time.
The organisms selected for testing were:
Staphylococcus aureus
Pseudomonas aeruginosa
These organisms are commonly associated with skin infections and biofilm formation.
Testing Method
Exposure Cycle
24-hour exposure periods
Organism inoculation
Surface contact simulation
Cleaning Process
Washed per manufacturer instructions
Antibacterial soap
Warm water rinse
Repeated Testing
CFU enumeration
20 successive exposure days
Baseline comparison
20-Day CFU Results
Baseline Measurements:
Staphylococcus aureus 38 CFU
Pseudomonas aeruginosa: 48 CFU
Observed Results Over 20 Days:
CFU counts remained under 100
No persistent colonization was observed
No evidence of long-term bacterial retention
A temporary spike occurred during testing when handled without gloves; counts returned to baseline following proper cleaning.
Study Conclusion
The Vented Derma Compress device remained resistant to Staphylococcus aureus and Pseudomonas aeruginosa over a 20-day use and cleaning cycle.
Testing indicates repeated exposure and cleaning did not result in cumulative microbial retention under laboratory conditions.
Technical Data
View Full CFU Data by Exposure Day
-
Baseline
Staphylococcus aureus: 38 CFU
Pseudomonas aeruginosa: 48 CFUDay 1
Staphylococcus aureus: 9 CFU
Pseudomonas aeruginosa: 3 CFUDay 2
Staphylococcus aureus: 7 CFU
Pseudomonas aeruginosa: 37 CFUDay 3
Staphylococcus aureus: 23,000 CFU*
Pseudomonas aeruginosa: 20,000 CFU*Day 4
Staphylococcus aureus: 2 CFU
Pseudomonas aeruginosa: 11 CFUDay 5
Staphylococcus aureus: 121 CFU
Pseudomonas aeruginosa: 460 CFU
*Day 3 spike associated with handling variation during testing. -
Day 6
Staphylococcus aureus: 6 CFU
Pseudomonas aeruginosa: 200 CFUDay 7
Staphylococcus aureus: 373 CFU
Pseudomonas aeruginosa: 328 CFUDay 8
Staphylococcus aureus: 69 CFU
Pseudomonas aeruginosa: 54 CFUDay 9
Staphylococcus aureus: 33 CFU
Pseudomonas aeruginosa: 15 CFUDay 10
Staphylococcus aureus: 45 CFU
Pseudomonas aeruginosa: 43 CFUDay 11
Staphylococcus aureus: 7 CFU
Pseudomonas aeruginosa: 30 CFUDay 12
Staphylococcus aureus: 3,136 CFU
Pseudomonas aeruginosa: 1,066 CFU -
Day 13
Staphylococcus aureus: 17 CFU
Pseudomonas aeruginosa: 19 CFUDay 14
Staphylococcus aureus: 44 CFU
Pseudomonas aeruginosa: 341 CFUDay 15
Staphylococcus aureus: 18 CFU
Pseudomonas aeruginosa: 151 CFUDay 16
Staphylococcus aureus: 23 CFU
Pseudomonas aeruginosa: 40 CFUDay 17
Staphylococcus aureus: 142 CFU
Pseudomonas aeruginosa: 18 CFUDay 18
Staphylococcus aureus: 26 CFU
Pseudomonas aeruginosa: 29 CFUDay 19
Staphylococcus aureus: 16 CFU
Pseudomonas aeruginosa: 5 CFUDay 20
Staphylococcus aureus: 21 CFU
Pseudomonas aeruginosa: 43 CFU
Disclaimer
Results reflect laboratory testing conditions and the specific product configuration evaluated.
CFU levels may vary based on real-world handling, environmental conditions, and hygiene practices.
This information is provided for educational and informational purposes and does not constitute a medical claim.